Cited by 362Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsGenetic and Kidney Cyst Diseases

The DOI matches its Crossref record; 110 of the 113 references it cites were found in a registry or an index.

Metabolic features of the reproductive phenotypes of polycystic ovary syndrome

Moran, Lisa, Teede, Helena·2009·Human Reproduction Update

DOI 10.1093/humupd/dmp008

Open this paper in CoChat — free account

Abstract

BACKGROUND Polycystic ovary syndrome (PCOS) is a common condition in women of reproductive age with well established metabolic abnormalities. There are numerous diagnostic criteria generating several reproductive diagnostic phenotypes [National Institute of Health (NIH) hyperandrogenic anovulatory PCOS and non-NIH PCOS including hyperandrogenic ovulatory or non-hyperandrogenic anovulatory PCOS]. There is ongoing debate regarding the optimal diagnostic criteria for PCOS and on the metabolic implications of newer non-NIH PCOS phenotypes. METHODS We reviewed the literature on the presence of risk factors for type 2 diabetes (DM2) and cardiovascular disease (CVD) across the reproductive diagnostic phenotypes of PCOS with the aims of comparing the metabolic features of the NIH and non-NIH groups and identifying potential high metabolic risk phenotypes of PCOS. RESULTS NIH PCOS patients present with greater obesity, abdominal obesity, insulin resistance (IR) and risk factors for DM2 and CVD compared with non-NIH ovulatory and non-hyperandrogenic PCOS patients. Where differences in metabolic features exist between the phenotypes, they are generally related to the degree of total and abdominal obesity. There is emerging evidence suggesting ovulatory and non-hyperandrogenic PCOS have greater metabolic abnormalities than controls primarily linked to abdominal adiposity. There is currently no evidence that non-hyperandrogenic PCOS is associated with a less adverse metabolic profile than ovulatory PCOS. CONCLUSIONS Current metabolic evidence appears to justify the inclusion of both non-NIH PCOS groups (ovulatory and non-hyperandrogenic) as PCOS subgroups. NIH PCOS is associated with a more adverse metabolic profile including greater total and abdominal obesity, IR and risk factors for CVD and DM2 than non-NIH phenotypes.

Integrity signals

Registry

Crossref · 10.1093/humupd/dmp008

Cites

110 of 110 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Withdrawn: Postmenopausal Women with a History of Irregular Menses and Elevated Androgen Measurements at High Risk for Worsening Cardiovascular Event-Free Survival: Results from the National Institutes of Health—National Heart, Lung, and Blood Institute Sponsored Women’s Ischemia Syndrome Evaluation
Shaw, L. J., Bairey Merz, C. N., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0425 · Cited by 427
Retracted
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yıldız, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,715
Clinical assessment of body hair growth in women.
Ferriman, D., & Gallwey, J. D. (1961) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,556
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132
Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study
Knochenhauer, E. S., Key, T. J., Kahsar-Miller, M., Waggoner, W., Boots, L. R., & Azziz, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5090 · Cited by 1,759
Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of pima indians
Lillioja, S., Mott, D. M., Spraul, M., Ferraro, R., Foley, J. E., Ravussin, E., Knowler, W. C., Bennett, P. H., & Bogardus, C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292703 · Cited by 1,508
Polycystic ovary syndrome
Norman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61345-2 · Cited by 1,360
A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain1
Asunción, M., Calvo, R. M., Millán, J. L. S., Sancho, J., Ávila, S., & Escobar-Morreale, H. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6682 · Cited by 1,328
Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study
Knochenhauer, E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.9.3078 · Cited by 1,134
A Survey of the Polycystic Ovary Syndrome in the Greek Island of Lesbos: Hormonal and Metabolic Profile
Diamanti‐Kandarakis, E., Kouli, C., Bergiele, A. T., Filandra, F. A., Tsianateli, T. C., Spina, G., Zapanti, E. D., & Bartzis, M. I. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6148 · Cited by 1,107
Andrology: Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients
Balen, A. H., Conway, G. S., Kaltsas, G., Techatraisak, K., Manning, P. J., West, C., & Jacobs, H. S. (1995) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a136243 · Cited by 1,060
Ultrasound assessment of the polycystic ovary: international consensus definitions
Balen, A. H., Laven, J. S. E., Tan, S.-L., & Dewailly, D. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg044 · Cited by 1,015
Polycystic ovary syndrome
Lawrence, J., Douglas, P., & Gandy, J. (2016) · doi:10.1002/9781119163411.ch73 · Cited by 1,014
Hirsutism: Implications, etiology, and management
Hatch, R., Rosenfield, R. L., Kim, M. H., & Tredway, D. R. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90746-8 · Cited by 1,013
Cardiovascular disease in women with polycystic ovary syndrome at long‐term follow‐up: a retrospective cohort study
Wild, S., Pierpoint, T., McKeigue, P., & Jacobs, H. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01000.x · Cited by 970
Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
Apridonidze, T., Essah, P. A., Iuorno, M. J., & Nestler, J. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1045 · Cited by 931
A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome
Boomsma, C. M., Eijkemans, M. J. C., Hughes, E. G., Visser, G. H. A., Fauser, B. C. J. M., & Macklon, N. S. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml036 · Cited by 852
A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain
Asuncion, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.7.2434 · Cited by 791
International Diabetes Federation: a consensus on Type 2 diabetes prevention
Alberti, K. G. M. M., Zimmet, P., & Shaw, J. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02157.x · Cited by 778
Prevalence and Predictors of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
Ehrmann, D. A., Liljenquist, D. R., Kasza, K., Azziz, R., Legro, R. S., & Ghazzi, M. N. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1329 · Cited by 703
Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome
Legro, R. S., Kunselman, A. R., & Dunaif, A. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00948-2 · Cited by 622
Health care-related economic burden of the polycystic ovary syndrome during the reproductive life Span
Azziz, R., Marin, C., Hoq, L., Badamgarav, E., & Song, P. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0628 · Cited by 537
POLYCYSTIC OVARY SYNDROME: A CHANGING PERSPECTIVE
Franks, S. (1989) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1989.tb00457.x · Cited by 523
Menopause and the Metabolic Syndrome The Study of Women's Health Across the Nation
Janssen, İ. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.14.1568 · Cited by 513
Mortality of Women with Polycystic Ovary Syndrome at Long-term Follow-up
Pierpoint, T., McKeigue, P. M., Isaacs, A. J., Wild, S. H., & Jacobs, H. S. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00035-3 · Cited by 504
PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO‐II anovulation and association with metabolic factors
Broekmans, F. J., Knauff, E. A. H., Valkenburg, O., Laven, J. S. E., Eijkemans, M. J. C., & Fauser, B. C. J. M. (2006) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.01008.x · Cited by 445
Diagnosis of Polycystic Ovarian Syndrome: The Rotterdam Criteria Are Premature
Azziz, R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2153 · Cited by 444
Relative Prevalence of Different Androgen Excess Disorders in 950 Women Referred because of Clinical Hyperandrogenism
Carmina, E., Rosato, F., Jannì, A., Rizzo, M., & Longo, R. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1457 · Cited by 420
Incidence of Type II Diabetes in Mexican Americans Predicted by Fasting Insulin and Glucose Levels, Obesity, and Body-Fat Distribution
Haffner, S. M., D, M. P. S. M., Mitchell, B. D., Hazuda, H. P., & Patterson, J. K. (1990) · Diabetes · doi:10.2337/diab.39.3.283 · Cited by 397
Insulin and Risk of Cardiovascular Disease
Ruige, J. B., Assendelft, W. J., Dekker, J. M., Kostense, P. J., Heine, R. J., & Bouter, L. M. (1998) · Circulation · doi:10.1161/01.cir.97.10.996 · Cited by 393
Abdominal adiposity and the polycystic ovary syndrome
Escobar-Morreale, H. F., & Millán, J. L. S. (2007) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2007.07.003 · Cited by 386
Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: An analysis of 263 consecutive cases
KIDDY, D. S., SHARP, P. S., WHITE, D. M., SCANLON, M. F., MASON, H. D., BRAY, C. S., POLSON, D. W., REED, M. J., & FRANKS, S. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00857.x · Cited by 364
Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome
Hart, R., Hickey, M., & Franks, S. (2004) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2004.05.001 · Cited by 358
How common are polycystic ovaries in normal women and what is their significance for the fertility of the population?
Clayton, R. N., Ogden, V., Hodgkinson, J., Worswick, L., Rodin, D. A., Dyer, S., & Meade, T. W. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02296.x · Cited by 357
Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?
Wijeyaratne, C. N., Balen, A. H., Barth, J. H., & Belchetz, P. E. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01603.x · Cited by 315
Insulin Resistance, the Metabolic Syndrome, and Incident Cardiovascular Events in the Framingham Offspring Study
Rutter, M. K., Meigs, J. B., SULLIVAN, L. M., D’Agostino, R. B., & Wilson, P. W. F. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3252 · Cited by 307
Molecular mechanisms of insulin resistance in polycystic ovary syndrome
Diamanti-Kandarakis, E., & Papavassiliou, A. G. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.05.006 · Cited by 301
Polycystic ovarian disease
Wallach, E. E., & Goldzieher, J. W. (1981) · Fertility and Sterility · doi:10.1016/s0015-0282(16)45429-4 · Cited by 296
Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups
Chang, W. Y., Knochenhauer, E. S., Bartolucci, A. A., & Azziz, R. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.01.096 · Cited by 284
The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries
Robinson, S., Kiddy, D. S., Gelding, S. V., Willis, D., Niththyananthan, R., Bush, A., Johnston, D. G., & Franks, S. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02376.x · Cited by 282
Diagnosis of Polycystic Ovarian Syndrome: In Defense of the Rotterdam Criteria
Franks, S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2501 · Cited by 278
A Prospective Study of Coronary Heart Disease in Relation to Fasting Insulin, Glucose, and Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study
Folsom, A. R., Szklo, M., Stevens, J., Liao, F., Smith, R. D., & Eckfeldt, J. H. (1997) · Diabetes Care · doi:10.2337/diacare.20.6.935 · Cited by 275
Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters
Carmina, E., Chu, M. C., Longo, R. A., Rini, G. B., & Lobo, R. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2279 · Cited by 274
Overweight Women with Polycystic Ovary Syndrome Have Evidence of Subclinical Cardiovascular Disease
Meyer, C., McGrath, B. P., & Teede, H. J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0011 · Cited by 273
Self-citation
Characterizing Discrete Subsets of Polycystic Ovary Syndrome as Defined by the Rotterdam Criteria: The Impact of Weight on Phenotype and Metabolic Features
Welt, C. K., Gudmundsson, J., Arason, G., Adams, J., Pálsdottir, H. S., Gudlaugsdottir, G. J., Ingadóttir, G., & Crowley, W. F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1327 · Cited by 260
Polycystic Ovary Syndrome
(2022) · Cambridge University Press eBooks · doi:10.1017/9781108989831 · Cited by 256
Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome
Barber, T. M., Wass, J. A. H., McCarthy, M. I., & Franks, S. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02764.x · Cited by 254
The Prevalence of Polycystic Ovaries on Ultrasound Scanning in a Population of Randomly Selected Women
Farquhar, C. M., Birdsall, M. A., Manning, P. J., Mitchell, J., & France, J. T. (1994) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.1994.tb01041.x · Cited by 246
Polycystic Ovary Syndrome and Mental Health: A Review
Himelein, M. J., & Thatcher, S. S. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000243772.33357.84 · Cited by 239
Treatment with Flutamide, Metformin, and Their Combination Added to a Hypocaloric Diet in Overweight-Obese Women with Polycystic Ovary Syndrome: A Randomized, 12-Month, Placebo-Controlled Study
Gambineri, A., Patton, L., Vaccina, A., Cacciari, M., Morselli-Labate, A. M., Cavazza, C., Pagotto, U., & Pasquali, R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2250 · Cited by 221
Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria
Juran, R., Syrop, C. H., Davis, W. A., Voorhis, B. J. V., & Dokras, A. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.01.032 · Cited by 214
Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS
Carmina, E., Napoli, N., Longo, R. A., Rini, G. B., & Lobo, R. A. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02058 · Cited by 202
Oligoanovulation with Polycystic Ovaries But Not Overt Hyperandrogenism
Dewailly, D., Catteau-Jonard, S., Reyss, A.-C., Leroy, M., & Pigny, P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1054 · Cited by 198
Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with Type II diabetes
Lehto, S., Rönnemaa, T., Pyörälà, K., & Laakso, M. (2000) · Diabetologia · doi:10.1007/s001250050023 · Cited by 192
Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: A comparison of two distinct populations
Kauffman, R. P., Baker, V. M., DiMarino, P., Gimpel, T., & Castracane, V. D. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.126650 · Cited by 188
Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women
Corbould, A. (2007) · Journal of Endocrinology · doi:10.1677/joe.1.07070 · Cited by 184
Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS
Diamanti‐Kandarakis, E., & Panidis, D. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02954.x · Cited by 183
Polycystic Ovarian Morphology with Regular Ovulatory Cycles: Insights into the Pathophysiology of Polycystic Ovarian Syndrome
Adams, J. M., Taylor, A. E., Crowley, W. F., & Hall, J. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031600 · Cited by 179
The assessment of acne: An evaluation of grading and lesion counting in the measurement of acne
Witkowski, J. A., & Parish, L. C. (2004) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2004.03.008 · Cited by 153
Comparison of Efficacy of Spironolactone with Metformin in the Management of Polycystic Ovary Syndrome: An Open-Labeled Study
Ganie, M. A., Khurana, M. L., Eunice, M., Gulati, M., Dwivedi, S. N., & Ammini, A. C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031780 · Cited by 151
Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome
Cussons, A. J., Watts, G. F., Burke, V., Shaw, J. E., Zimmet, P. Z., & Stuckey, B. G. A. (2008) · Human Reproduction · doi:10.1093/humrep/den263 · Cited by 140
Risk of T2DM and impaired fasting glucose among pcos subjects: Results of an 8-year follow-up
Boudreaux, M. Y., Talbott, E. O., Kip, K. E., Brooks, M. M., & Witchel, S. F. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0056-1 · Cited by 139
Anti-Mullerian Hormone Levels in Peripubertal Daughters of Women with Polycystic Ovary Syndrome
Crisosto, N., Ethel Codner, D., Maliqueo, M. A., Echiburú, B., Sánchez, F., CASSORLA, F. G., & Sir‐Petermann, T. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0267 · Cited by 138
The management of insulin resistance in polycystic ovary syndrome
Teede, H. J., Hutchison, S. K., & Zoungas, S. (2007) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2007.08.001 · Cited by 135
Self-citation
Defining ConstantVersusVariable Phenotypic Features of Women with Polycystic Ovary Syndrome Using Different Ethnic Groups and Populations
Welt, C. K., Arason, G., Gudmundsson, J., Adams, J., Pálsdottir, H. S., Gudlaugsdottir, G. J., Ingadóttir, G., & Crowley, W. F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1191 · Cited by 127
Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women
Chae, S. J., Kim, J. J., Choi, Y. M., Hwang, K. R., Jee, B. C., Ku, S., Suh, C. S., Kim, S. H., Kim, J. G., & Moon, S. Y. (2008) · Human Reproduction · doi:10.1093/humrep/den239 · Cited by 127
Polycystic Ovaries Are Common in Women with Hyperandrogenic Chronic Anovulation but Do Not Predict Metabolic or Reproductive Phenotype
Legro, R. S., Chiu, P., Kunselman, A. R., Bentley, C. M., Dodson, W. C., & Dunaif, A. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0219 · Cited by 125
Assessment of Insulin Sensitivity from Measurements in the Fasting State and during an Oral Glucose Tolerance Test in Polycystic Ovary Syndrome and Menopausal Patients
Ciampelli, M., Leoni, F., Cucinelli, F., Mancuso, S., Panunzi, S., Gaetano, A. D., & Lanzone, A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0410 · Cited by 120
Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria
Kauffman, R. P., Baker, T. E., Baker, V. M., DiMarino, P., & Castracane, V. D. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.01.037 · Cited by 113
The prevalence of polycystic ovaries in women with infertility
Κousta, E., White, D. M., Cela, E., McCarthy, M. I., & Franks, S. (1999) · Human Reproduction · doi:10.1093/humrep/14.11.2720 · Cited by 113
Clinical features in women with polycystic ovaries: relationships to insulin sensitivity, insulin gene VNTR and birth weight
Michelmore, K. F., Ong, K. K., MASON, S. A., Bennett, S. T., Perry, L., Vessey, M. P., Balen, A. H., & Dunger, D. B. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01375.x · Cited by 112
Fasting Serum Insulin Concentration and Early Insulin Response as Risk Determinants for Developing Diabetes
Lundgren, H., Bengtsson, C., Blohmé, G., Lapidus, L., & Waldenström, J. (1990) · Diabetic Medicine · doi:10.1111/j.1464-5491.1990.tb01415.x · Cited by 103
Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome
Carmina, E., Bucchieri, S., Mansueto, P., Rini, G., Ferin, M., & Løbo, R. A. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.03.007 · Cited by 103
Ethnic differences in insulin and glucose response to glucose between white and Indian women with polycystic ovary syndrome
Norman, R. J., Mahabeer, S., & Masters, S. C. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57297-5 · Cited by 102
Vascular Dysfunction and Metabolic Parameters in Polycystic Ovary Syndrome
Meyer, C., McGrath, B. P., Cameron, J., Kotsopoulos, D., & Teede, H. J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1487 · Cited by 101
Self-citation
Polycystic ovaries in hirsute women with normal menses
Carmina, E., & Løbo, R. A. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00979-2 · Cited by 101
Do hyperandrogenic women with normal menses have polycystic ovary syndrome?
Carmina, E., & Løbo, R. A. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00455-5 · Cited by 97
Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome
Sam, S., Legro, R. S., Essah, P. A., Apridonidze, T., & Dunaif, A. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602025103 · Cited by 96
Endocrinology: Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome
Norman, R. J., Hague, W. M., Masters, S. C., & Wang, X. J. (1995) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a136280 · Cited by 85
Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma?
Belosi, C., Selvaggi, L. E., Apa, R., Guido, M., Romualdi, D., Fulghesu, A. M., & Lanzone, A. (2006) · Human Reproduction · doi:10.1093/humrep/del306 · Cited by 85
Plasma homocysteine in polycystic ovary syndrome: does it correlate with insulin resistance and ethnicity?
Wijeyaratne, C. N., Nirantharakumar, K., Balen, A. H., Barth, J. H., Sheriff, R., & Belchetz, P. E. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02019.x · Cited by 82
Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome
Yılmaz, M., Bukan, N. C., Ersoy, R., Karakoç, A., Yetkin, İ., Ayvaz, G., Çakır, N., & Arslan, M. (2005) · Human Reproduction · doi:10.1093/humrep/dei070 · Cited by 81
Impaired Carotid Viscoelastic Properties in Women With Polycystic Ovaries
Lakhani, K., Seifalian, A. M., & Hardiman, P. J. (2002) · Circulation · doi:10.1161/01.cir.0000020681.19400.8a · Cited by 80
Diagnostic criteria for polycystic ovary syndrome in Taiwanese Chinese women: comparison between Rotterdam 2003 and NIH 1990
Hsu, M.-I., Liou, T., Chou, S.-Y., Chang, C.-Y., & Hsu, C.-S. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.11.149 · Cited by 77
Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome
Essah, P. A., Nestler, J. E., & Carmina, E. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03345564 · Cited by 74
Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects
Baillargeon, J., & Carpentier, A. C. (2007) · Diabetologia · doi:10.1007/s00125-007-0831-9 · Cited by 72
Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population
Pehlivanov, B. K., & Orbetzova, M. M. (2007) · Gynecological Endocrinology · doi:10.1080/09513590701536246 · Cited by 70
Correlation of plasma insulin and insulin‐like growth factor‐I with indices of androgen transport and metabolism in women with polycystic ovary syndrome
Sharp, P. S., Kiddy, D. S., Reed, M. J., Anyaoku, V., Johnston, D. G., & Franks, S. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb03531.x · Cited by 67
Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome?
Loucks, T. L., Talbott, E. O., McHugh-Pemu, K. P., Keelan, M. H., Berga, S. L., & Guzick, D. S. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(00)00695-6 · Cited by 65
The ESHRE/ASRM consensus on polycystic ovary syndrome (PCOS) – an extended critical analysis
Geisthövel, F., & Rabe, T. (2007) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60902-9 · Cited by 56
Acne vulgaris, I: pathogenesis and diagnosis.
Oberemok, S. S., & Shalita, A. R. (2002) · PubMed · Cited by 50
Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam’s criteria and women whose only clinical signs are oligo/anovulation or hirsutism
Hassa, H., Tanir, H. M., & Yıldız, Z. (2006) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-006-0173-8 · Cited by 48
Metabolic syndrome in females with polycystic ovary syndrome and International Diabetes Federation criteria
Bhattacharya, S. M. (2007) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2007.00685.x · Cited by 45
Hyperinsulinemia and circulating dehydroepiandrosterone sulfate in white and Mexican American women with polycystic ovary syndrome
Kauffman, R. P., Baker, V. M., DiMarino, P., & Castracane, V. D. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.09.046 · Cited by 44
Insulin levels in insulin resistance: phantom of the metabolic opera?
Samaras, K., McElduff, A., Twigg, S. M., Proietto, J., Prins, J. B., Welborn, T. A., Zimmet, P., Chisholm, D. J., & Campbell, L. V. (2006) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2006.tb00506.x · Cited by 42
Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study
Şahin, İ., Serter, R., Karakurt, F., Demirbas, B. T., Çulha, C., Taşkapan, Ç., Koşar, F., & Aral, Y. (2004) · Gynecological Endocrinology · doi:10.1080/09513590400004736 · Cited by 34
Insulin resistance and lipid profile in women with polycystic appearing ovaries: implications with regard to polycystic ovary syndrome
Sayın, N. C., Güçer, F., Balkanlı-Kaplan, P., Yuce, M. A., & Yardım, T. (2003) · Gynecological Endocrinology · doi:10.1080/09513590312331290278 · Cited by 32
The Combination of Increased Ovarian Volume and Follicle Number is Associated with More Severe Hyperandrogenism in German Women with Polycystic Ovary Syndrome
Hahn, S., van Halteren, W. B., Roesler, S., Schmidt, M., Kimmig, R., Tan, S., Mann, K., & Janssen, O. E. (2006) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2006-924063 · Cited by 25
Flutamide Suppresses Adrenal Steroidogenesis but Has No Effect on Insulin Resistance and Secretion and Lipid Levels in Overweight Women with Polycystic Ovary Syndrome
Vrbíková, J., Hill, M., Dvořáková, K., Stanická, S., Vondra, K., & Stárka, L. (2004) · Gynecologic and Obstetric Investigation · doi:10.1159/000077827 · Cited by 24
Insulin Responses to the Oral Glucose Tolerance Test in Women of Different Ethnicity With Polycystic Ovary Syndrome
Al-Fozan, H. M., Al-Futaisi, A., Morris, D., & Tulandi, T. (2005) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)30169-4 · Cited by 19
Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women
Shi, Y., Gao, X., Sun, X., Zhang, P., & Chen, Z. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.07.1375 · Cited by 19
Insulin resistance in polycystic ovary syndrome: hyperandrogenemia versus normoandrogenemia
Yıldız, B. O., & Gedik, O. (2001) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(01)00458-4 · Cited by 18
The significance of polycystic-appearing ovaries versus normalappearing ovaries in patients with polycystic ovary syndrome
Najmabadi, S., Wilcox, J., Acacio, B., Thornton, M. H., Kolb, B. A., & Paulson, R. J. (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)81357-x · Cited by 16
Does ovarian blood flow distinguish between ovulatory and anovulatory patients with polycystic ovary syndrome?
Carmina, E., Longo, A., & Løbo, R. A. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/s0002-9378(03)00832-9 · Cited by 15
Investigation of hypothalamo-pituitary-gonadal axis and glucose intolerance among the first-degree female relatives of women with polycystic ovary syndrome
Ünlühızarcı, K., Özocak, M., Tanrıverdi, F., Atmaca, H., & Keleştimur, F. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.11.075 · Cited by 13

Sorted by citations

Polycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment
Escobar-Morreale, H. F. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.24 · Cited by 2,083
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
Fauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. E., et al. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.024 · Cited by 1,976
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
Teede, H., Deeks, A., & Moran, L. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-41 · Cited by 1,565
Self-citation
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.217 · Cited by 1,488

See all 362

Authors: Moran, L., & Teede, H.
Affiliations: Jean Hailes (AU)
Corresponding author: Moran, Lisa
ORCID: Moran, Lisa
Teede, Helena
Venue: Human Reproduction Update
Publisher: Oxford University Press (OUP)
Published: 2009
Volume: 15
Issue: 4
Pages: 477-488
ISSN: 1355-4786 (ISSN-L)
1460-2369
DOI: 10.1093/humupd/dmp008
OpenAlex: W2102318195
Cited by: 362
References: 113
Citations by year: 2026: 10 · 2025: 15 · 2024: 11 · 2023: 20 · 2022: 18 · 2021: 28 · 2020: 23 · 2019: 19 · 2018: 21 · 2017: 18 · 2016: 25 · 2015: 23 · 2014: 25 · 2013: 30 · 2012: 21
FWCI: 3.58
Type: journal article
Language: en
Open access: closed
Locations: Human Reproduction Update (publishedVersion)
PubMed (publishedVersion)
Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
Keywords: polycystic ovary syndrome, PCOS diagnostic criteria, metabolic abnormalities, insulin resistance, abdominal obesity, type 2 diabetes risk, cardiovascular risk
MeSH terms: Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Humans, Insulin Resistance, Phenotype, Polycystic Ovary Syndrome, Risk Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Metabolic features of the reproductive phenotypes of polycystic ovary syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks